This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Maréchal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol 2013; 5: a012716. doi: 10.1101/cshperspect.a012716MaréchalAZouLDNA damage sensing by the ATM and ATR kinases20135a01271610.1101/cshperspect.a012716375370724003211Open DOISearch in Google Scholar
Eriksson D, Stigbrand T. Radiation-induced cell death mechanisms. Tumor Biol 2010; 31: 363-72. doi: 10.1007/s13277-010-0042-8ErikssonDStigbrandTRadiation-induced cell death mechanisms2010313637210.1007/s13277-010-0042-820490962Open DOISearch in Google Scholar
Lomax ME, Folkes LK, O’Neill P. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol 2013; 25: 578-85. doi: 10.1016/j.clon.2013.06.007LomaxMEFolkesLKO’NeillPBiological consequences of radiation-induced DNA damage: relevance to radiotherapy2013255788510.1016/j.clon.2013.06.00723849504Open DOISearch in Google Scholar
Hu J, Lieb JD, Sancar A, Adar S. Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution. Proc Natl Acad Sci 2016; 13: 11507-12. doi: 10.1073/pnas.1614430113HuJLiebJDSancarAAdarSCisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution201613115071210.1073/pnas.1614430113506833727688757Open DOISearch in Google Scholar
Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31: 1869-83. doi: 10.1038/onc.2011.384GalluzziLSenovillaLVitaleIMichelsJMartinsIKeppOet alMolecular mechanisms of cisplatin resistance20123118698310.1038/onc.2011.38421892204Open DOISearch in Google Scholar
Makovec T. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy. Radiol Oncol 2019; 53: 148-58. doi: 10.2478/raon-2019-0018MakovecTCisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy2019531485810.2478/raon-2019-0018657249530956230Open DOISearch in Google Scholar
Chen J, Stubbe J. Bleomycins: towards better therapeutics. Nat Rev Cancer 2005; 5: 102-12. doi: 10.1038/nrc1547ChenJStubbeJBleomycins: towards better therapeutics200551021210.1038/nrc154715685195Open DOISearch in Google Scholar
Allawzi A, Elajaili H, Redente EF, Nozik-Grayck E. Oxidative toxicology of bleomycin: role of the extracellular redox environment. Physiol Behav 2016; 176: 139-48. doi: 10.1016/j.cotox.2018.08.001AllawziAElajailiHRedenteEFNozik-GrayckEOxidative toxicology of bleomycin: role of the extracellular redox environment20161761394810.1016/j.cotox.2018.08.001661575231289762Open DOISearch in Google Scholar
Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AWM, et al. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck 2015; 37: 134-50. doi: 10.1002/hed.23542StrojanPCorryJEisbruchAVermorkenJBMendenhallWMLeeAWMet alRecurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate2015371345010.1002/hed.2354224481720Open DOISearch in Google Scholar
Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 2011; 100: 33-40. doi: 10.1016/j.radonc.2011.05.036BlanchardPBaujatBHolostencoVBourredjemABaeyCBourhisJet alMeta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site2011100334010.1016/j.radonc.2011.05.03621684027Open DOISearch in Google Scholar
Benson E, Li R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol 2014; 50: 56574. doi: 10.1016/j.oraloncology.2013.09.008BensonELiREiseleDFakhryCThe clinical impact of HPV tumor status upon head and neck squamous cell carcinomas2014505657410.1016/j.oraloncology.2013.09.008439170624134947Open DOISearch in Google Scholar
Mirghani H, Amen F, Tao Y, Deutsch E, Levy A. Increased radiosensitivity of HPV-positive head and neck cancers: molecular basis and therapeutic perspectives. Cancer Treat Rev 2015; 41: 844-52. doi: 10.1016/j.ctrv.2015.10.001MirghaniHAmenFTaoYDeutschELevyAIncreased radiosensitivity of HPV-positive head and neck cancers: molecular basis and therapeutic perspectives2015418445210.1016/j.ctrv.2015.10.00126476574Open DOISearch in Google Scholar
Wierzbicka M, Szyfter K, Milecki P, Składowski K, Ramlau R. The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies. Contemp Oncol 2015; 19: 313-22. doi: 10.5114/wo.2015.54389WierzbickaMSzyfterKMileckiPSkładowskiKRamlauRThe rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies2015193132210.5114/wo.2015.54389463130726557780Open DOISearch in Google Scholar
Prevc A, Kranjc S, Cemazar M, Todorovic V, Zegura B, Novak M, et al. Dose-modifying factor of radiation therapy with concurrent cisplatin treatment in HPV-positive squamous cell carcinoma: a preclinical study. Radiat Res 2018; 189: 644-51. doi: 10.1667/RR14984.1PrevcAKranjcSCemazarMTodorovicVZeguraBNovakMet alDose-modifying factor of radiation therapy with concurrent cisplatin treatment in HPV-positive squamous cell carcinoma: a preclinical study20181896445110.1667/RR14984.129652621Open DOISearch in Google Scholar
Kimple RJ, Harari PM. Is radiation dose reduction the right answer for HPV-positive head and neck cancer? Oral Oncol 2014; 50: 560-4. doi: 10.1016/j.oraloncology.2013.09.015KimpleRJHarariPMIs radiation dose reduction the right answer for HPV-positive head and neck cancer?201450560410.1016/j.oraloncology.2013.09.015398634624134946Open DOISearch in Google Scholar
Adema AD, Cloos J, Verheijen RHM, Braakhuis BJM, Bryant PE. Comparison of bleomycin and radiation in the G2 assay of chromatid breaks. Int J Radiat Biol 2003; 79: 655-61. doi: 10.1080/09553000310001596968AdemaADCloosJVerheijenRHMBraakhuisBJMBryantPEComparison of bleomycin and radiation in the G2 assay of chromatid breaks2003796556110.1080/0955300031000159696814555348Open DOISearch in Google Scholar
O’Connor MJ. Targeting the DNA damage response in cancer. Mol Cell 2015; 60: 547-60. doi: 10.1016/j.molcel.2015.10.040O’ConnorMJTargeting the DNA damage response in cancer2015605476010.1016/j.molcel.2015.10.04026590714Open DOISearch in Google Scholar
Brown JS, O’Carrigan B, Jackson SP, Yap TA. Targeting DNA repair in cancer: beyond PARP inhibitors. Cancer Discov 2017; 7: 20-37. doi: 10.1158/2159-8290.CD-16-0860BrownJSO’CarriganBJacksonSPYapTATargeting DNA repair in cancer: beyond PARP inhibitors20177203710.1158/2159-8290.CD-16-0860530009928003236Open DOISearch in Google Scholar
Kimple RJ, Smith MA, Blitzer GC, Torres AD, Martin JA, Yang RZ, et al. Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res 2013; 73: 4791-800. doi: 10.1158/0008-5472.CAN-13-0587KimpleRJSmithMABlitzerGCTorresADMartinJAYangRZet alEnhanced radiation sensitivity in HPV-positive head and neck cancer201373479180010.1158/0008-5472.CAN-13-0587373254023749640Open DOISearch in Google Scholar
Park JW, Nickel KP, Torres AD, Lee D, Lambert PF, Kimple RJ. Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage. Radiother Oncol 2014; 113: 337-44. doi: 10.1016/j.radonc.2014.08.026ParkJWNickelKPTorresADLeeDLambertPFKimpleRJHuman papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage20141133374410.1016/j.radonc.2014.08.026426837225216575Open DOISearch in Google Scholar
Spanos WC, Nowicki P, Lee DW, Hoover A, Hostager B, Gupta A, et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol - Head Neck Surg 2009; 135: 1137-46. doi: 10.1001/archoto.2009.159SpanosWCNowickiPLeeDWHooverAHostagerBGuptaAet alImmune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer200913511374610.1001/archoto.2009.15919917928Open DOISearch in Google Scholar
McDermott N, Meunier A, Lynch TH, Hollywood D, Marignol L. Isogenic radiation resistant cell lines: development and validation strategies. Int J Radiat Biol 2014; 90: 115-26. doi: 10.3109/09553002.2014.873557McDermottNMeunierALynchTHHollywoodDMarignolLIsogenic radiation resistant cell lines: development and validation strategies2014901152610.3109/09553002.2014.87355724350914Open DOISearch in Google Scholar
Todorovic V, Prevc A, Zakelj MN, Savarin M, Brozic A, Groselj B, et al. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines. Radiat Oncol 2019; 14: 1-20. doi: 10.1186/ s13014-019-1418-6TodorovicVPrevcAZakeljMNSavarinMBrozicAGroseljBet alMechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines20191412010.1186/s13014-019-1418-6688234831775835Open DOISearch in Google Scholar
Harris M, Wang XG, Jiang Z, Goldberg GL, Casadevall A, Dadachova E. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line. Head Neck Oncol 2011; 3: 9. doi: 10.1186/1758-3284-3-9HarrisMWangXGJiangZGoldbergGLCasadevallADadachovaERadioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line20113910.1186/1758-3284-3-9304692521314983Open DOISearch in Google Scholar
Reiss M, Brash D, Muñoz-Antonia T, Simon J, Ziegler A, Vellucci V, et al. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol Res 1992; 4: 349-57. PMID:1486218ReissMBrashDMuñoz-AntoniaTSimonJZieglerAVellucciVet alStatus of the p53 tumor suppressor gene in human squamous carcinoma cell lines1992434957PMID:1486218Search in Google Scholar
Prevc A, Niksic Zakelj M, Kranjc S, Cemazar M, Scancar J, Kosjek T, et al. Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: improved effectiveness of cisplatin in HPV-positive tumors. Bioelectrochemistry 2018; 123: 248-54. doi: 10.1016/j.bioelechem.2018.06.004PrevcANiksicZakelj MKranjcSCemazarMScancarJKosjekTet alElectrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: improved effectiveness of cisplatin in HPV-positive tumors20181232485410.1016/j.bioelechem.2018.06.00429898433Open DOISearch in Google Scholar
Zakelj MN, Prevc A, Kranjc S, Cemazar M, Todorovic V, Savarin M, et al. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts. Oncol Rep 2019; 41: 1658-68. doi: 10.3892/or.2019.6960ZakeljMNPrevcAKranjcSCemazarMTodorovicVSavarinMet alElectrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts20194116586810.3892/or.2019.6960636570530628709Open DOISearch in Google Scholar
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034. doi: 10.1186/gb-2002-3-7-research0034VandesompeleJDe PreterKPattynFPoppeBVanRoy NDe PaepeAet alAccurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes20023: RESEARCH003410.1186/gb-2002-3-7-research003412623912184808Open DOISearch in Google Scholar
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001; 25: 402-8. doi: 10.1006/meth.2001.1262LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))200125402810.1006/meth.2001.126211846609Open DOISearch in Google Scholar
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74. doi: 10.1016/j.cell.2011.02.013HanahanDWeinbergRAHallmarks of cancer: the next generation20111446467410.1016/j.cell.2011.02.01321376230Open DOISearch in Google Scholar
Blasiak J. DNA-damaging anticancer drugs – a perspective for DNA repair-oriented therapy. Curr Med Chem 2017; 24: 1488-503. doi: 10.2174/0929867324666170124145557BlasiakJDNA-damaging anticancer drugs – a perspective for DNA repair-oriented therapy201724148850310.2174/092986732466617012414555728120709Open DOISearch in Google Scholar
Arenz A, Ziemann F, Mayer C, Wittig A, Dreffke K, Preising S, et al. Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis. Strahlenther Onkol 2014; 190: 839-46. doi: 10.1007/s00066-014-0605-5ArenzAZiemannFMayerCWittigADreffkeKPreisingSet alIncreased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis20141908394610.1007/s00066-014-0605-524715240Open DOISearch in Google Scholar
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-9. doi: 10.1093/jnci/djn011FakhryCWestraWHLiSCmelakARidgeJAPintoHet alImproved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial2008100261910.1093/jnci/djn01118270337Open DOISearch in Google Scholar
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35. doi: 10.1056/NEJMoa0912217AngKKHarrisJWheelerRWeberRRosenthalDINguyen-TânPFet alHuman papillomavirus and survival of patients with oropharyngeal cancer2010363243510.1056/NEJMoa0912217294376720530316Open DOISearch in Google Scholar
Rieckmann T, Tribius S, Grob TJ, Meyer F, Busch C-JJ, Petersen C, et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiother Oncol 2013; 107: 242-6. doi: 10.1016/j.radonc.2013.03.013RieckmannTTribiusSGrobTJMeyerFBuschC-JJPetersenCet alHNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity2013107242610.1016/j.radonc.2013.03.01323602369Open DOISearch in Google Scholar
Masterson L, Moualed D, Liu ZW, Howard JEF, Dwivedi RC, Tysome JR, et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials. Eur J Cancer 2014; 50: 2636-48. doi: 10.1016/j.ejca.2014.07.001MastersonLMoualedDLiuZWHowardJEFDwivediRCTysomeJRet alDe-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials20145026364810.1016/j.ejca.2014.07.00125091798Open DOISearch in Google Scholar
Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell 2017; 66: 801-17. doi: 10.1016/j.molcel.2017.05.015BlackfordANJacksonSPATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response2017668011710.1016/j.molcel.2017.05.01528622525Open DOISearch in Google Scholar
McGowan CH, Russell P. The DNA damage response: sensing and signaling. Curr Opin Cell Biol 2004; 16: 629-33. doi: 10.1016/j.ceb.2004.09.005McGowanCHRussellPThe DNA damage response: sensing and signaling2004166293310.1016/j.ceb.2004.09.00515530773Open DOISearch in Google Scholar
Buisson R, Niraj J, Rodrigue A, Ho CK, Kreuzer J, Foo TK, et al. Coupling of homologous recombination and the checkpoint by ATR. Mol Cell 2017; 65: 336-46. doi: 10.1016/j.molcel.2016.12.007BuissonRNirajJRodrigueAHoCKKreuzerJFooTKet alCoupling of homologous recombination and the checkpoint by ATR2017653364610.1016/j.molcel.2016.12.007549677228089683Open DOISearch in Google Scholar
Leonard BC, Lee ED, Bhola NE, Li H, Sogaard KK, Bakkenist CJ, et al. ATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin. Oral Oncol 2019; 95: 35-42. doi: 10.1016/j.oraloncol-ogy.2019.05.028LeonardBCLeeEDBholaNELiHSogaardKKBakkenistCJet alATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin201995354210.1016/j.oraloncol-ogy.2019.05.028Open DOISearch in Google Scholar
Sankunny M, Parikh RA, Lewis DW, Gooding WE, Saunders WS, Gollin SM. Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss. Genes Chromosomes Cancer 2014; 53: 129-43. doi: 10.1002/gcc.22125SankunnyMParikhRALewisDWGoodingWESaundersWSGollinSMTargeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss2014531294310.1002/gcc.22125421659324327542Open DOISearch in Google Scholar
Wang H, Wang H, Powell SN, Iliakis G, Wang Y. ATR Affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining. Cancer Res 2004; 64: 7139-43. doi: 10.1158/0008-5472.CAN-04-1289WangHWangHPowellSNIliakisGWangYATR Affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining20046471394310.1158/0008-5472.CAN-04-128915466211Open DOISearch in Google Scholar
Bian L, Meng Y, Zhang M, Li D. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Molecular Cancer 2019; 18: 169. doi: 10.1186/s12943-019-1100-5BianLMengYZhangMLiDMRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment20191816910.1186/s12943-019-1100-5687866531767017Open DOISearch in Google Scholar
Prati B, da Silva Abjaude W, Termini L, Morale M, Herbster S, Longatto-Filho A, et al. Three Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo. Sci Rep 2019; 9: 351. doi: 10.1038/s41598-018-37064-xPratiBda SilvaAbjaude WTerminiLMoraleMHerbsterSLongatto-FilhoAet alThree Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo2019935110.1038/s41598-018-37064-x634451830674977Open DOISearch in Google Scholar
Girard PM, Foray N, Stumm M, Waugh A, Riballo E, Maser RS, et al. Radiosensitivity in nijmegen breakage syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects. Cancer Res 2000; 60: 4881-8. PMID: 10987302GirardPMForayNStummMWaughARiballoEMaserRSet alRadiosensitivity in nijmegen breakage syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects20006048818PMID: 10987302Search in Google Scholar
Cheng J, Liu W, Zeng X, Zhang B, Guo Y, Qiu M, et al. XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma. Cancer Sci 2015; 106: 1678-86. doi: 10.1111/cas.12820ChengJLiuWZengXZhangBGuoYQiuMet alXRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma201510616788610.1111/cas.12820471466426383967Open DOISearch in Google Scholar
Westermark UK, Reyngold M, Olshen AB, Baer R, Jasin M, Moynahan ME. BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks. Mol Cell Biol 2003; 23: 7926-36. doi: 10.1128/mcb.23.21.7926-7936.2003WestermarkUKReyngoldMOlshenABBaerRJasinMMoynahanMEBARD1 participates with BRCA1 in homology-directed repair of chromosome breaks20032379263610.1128/mcb.23.21.7926-7936.200320764514560035Open DOISearch in Google Scholar
Isono M, Niimi A, Oike T, Hagiwara Y, Sato H, Sekine R, et al. BRCA1 directs the repair pathway to homologous recombination by promoting 53BP1 dephosphorylation. Cell Rep 2017; 18: 520-32. doi: 10.1016/j.cel-rep.2016.12.042IsonoMNiimiAOikeTHagiwaraYSatoHSekineRet alBRCA1 directs the repair pathway to homologous recombination by promoting 53BP1 dephosphorylation2017185203210.1016/j.cel-rep.2016.12.042Open DOISearch in Google Scholar
Kakarougkas A, Jeggo PA. DNA DSB repair pathway choice: an orchestrated handover mechanism. Br J Radiol 2014; 87: 20130685. doi: 10.1259/bjr.20130685KakarougkasAJeggoPADNA DSB repair pathway choice: an orchestrated handover mechanism2014872013068510.1259/bjr.20130685406459824363387Open DOISearch in Google Scholar
Litwin I, Pilarczyk E, Wysocki R. The emerging role of cohesin in the DNA damage response. Genes 2018; 9: 581. doi: 10.3390/genes9120581LitwinIPilarczykEWysockiRThe emerging role of cohesin in the DNA damage response2018958110.3390/genes9120581631600030487431Open DOISearch in Google Scholar
Basu A, Krishnamurthy S. Cellular responses to cisplatin-induced DNA damage. J Nucleic Acids 2010; 2010: 1-16. doi: 10.4061/2010/201367BasuAKrishnamurthySCellular responses to cisplatin-induced DNA damage2010201011610.4061/2010/201367292960620811617Open DOISearch in Google Scholar
Marullo R, Werner E, Zhang H, Chen GZ, Shin DM, Doetsch PW. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Carcinogenesis 2015; 36: 1397-406. doi: 10.1093/carcin/bgv126MarulloRWernerEZhangHChenGZShinDMDoetschPWHPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells201536139740610.1093/carcin/bgv126475124726354779Open DOISearch in Google Scholar
Harvie RM, Davey MW, Davey RA. Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated gamma-radiation. Int J Cancer 1997; 73: 164-7. doi: 10.1002/(SICI)1097-0215(19970926)73:1<164::AID-IJC25>3.0.CO;2-FHarvieRMDaveyMWDaveyRAIncreased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated gamma-radiation199773164710.1002/(SICI)1097-0215(19970926)73:1<164::AID-IJC25>3.0.CO;2-FOpen DOISearch in Google Scholar
McDermott N, Meunier A, Mooney B, Nortey G, Hernandez C, Hurley S, et al. Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep 2016; 6: 34796. doi: 10.1038/srep34796McDermottNMeunierAMooneyBNorteyGHernandezCHurleySet alFractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells201663479610.1038/srep34796Open DOISearch in Google Scholar
Skvortsov S, Dudás J, Eichberger P, Witsch-Baumgartner M, Loeffler-Ragg J, Pritz C, et al. Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). Br J Cancer 2014; 110: 2677-87. doi: 10.1038/bjc.2014.221SkvortsovSDudásJEichbergerPWitsch-BaumgartnerMLoeffler-RaggJPritzCet alRac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)201411026778710.1038/bjc.2014.221Open DOISearch in Google Scholar
Wei QC, Shen L, Zheng S, Zhu YL. Isolation and characterization of radiation-resistant lung cancer D6-R cell line. Biomed Environ Sci 2008; 21: 339-44. doi: 10.1016/S0895-3988(08)60052-5WeiQCShenLZhengSZhuYLIsolation and characterization of radiation-resistant lung cancer D6-R cell line2008213394410.1016/S0895-3988(08)60052-5Open DOISearch in Google Scholar
Xie L, Song X, Yu J, Wei L, Song B, Wang X, et al. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. J Exp Clin Cancer Res 2009; 28: 68. doi: 10.1186/1756-9966-28-68XieLSongXYuJWeiLSongBWangXet alFractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs2009286810.1186/1756-9966-28-68Open DOISearch in Google Scholar
Kleinsimon S, Longmuss E, Rolff J, Jäger S, Eggert A, Delebinski C, et al. GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway. Sci Rep 2018; 8: 1-14. doi: 10.1038/s41598-018-24075-xKleinsimonSLongmussERolffJJägerSEggertADelebinskiCet alGADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway2018811410.1038/s41598-018-24075-xOpen DOISearch in Google Scholar
Rosemary Siafakas A, Richardson DR. Growth arrest and DNA damage-45 alpha (GADD45α). Int J Biochem Cell Biol 2009; 41: 986-9. doi: 10.1016/j.biocel.2008.06.018RosemarySiafakas ARichardsonDRGrowth arrest and DNA damage-45 alpha (GADD45α)200941986910.1016/j.biocel.2008.06.018Open DOISearch in Google Scholar
Wang BX, Yin BL, He B, Chen C, Zhao M, Zhang WX, et al. Overexpression of DNA damage-induced 45 a gene contributes to esophageal squamous cell cancer by promoter hypomethylation. J Exp Clin Cancer Res 2012; 31: 11. doi: 10.1186/1756-9966-31-11WangBXYinBLHeBChenCZhaoMZhangWXet alOverexpression of DNA damage-induced 45 a gene contributes to esophageal squamous cell cancer by promoter hypomethylation2012311110.1186/1756-9966-31-11Open DOISearch in Google Scholar
Barreto G, Schäfer A, Swaminathan SK, Döderlein G, Maltry N, Stach D, et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 2007; 445: 671-5. doi: 10.1038/nature05515BarretoGSchäferASwaminathanSKDöderleinGMaltryNStachDet alGadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation2007445671510.1038/nature05515Open DOISearch in Google Scholar
Tamura R, Vasconcellos JF De, Libermann T, Israel B, Medical D, Fisher PB, et al. GADD45 proteins: central players in tumorigenesis. Curr Mol Med 2012; 12: 634-51. doi: 10.2174/156652412800619978TamuraRVasconcellosJF DeLibermannTIsraelBMedicalDFisherPBet alGADD45 proteins: central players in tumorigenesis2012126345110.2174/156652412800619978Open DOISearch in Google Scholar
Liu J, Jiang G, Mao P, Zhang J, Zhang L, Liu L, et al. Down-regulation of GADD45A enhances chemosensitivity in melanoma. Sci Rep 2018; 8: 4111. doi: 10.1038/s41598-018-22484-6LiuJJiangGMaoPZhangJZhangLLiuLet alDown-regulation of GADD45A enhances chemosensitivity in melanoma20188411110.1038/s41598-018-22484-6584142629515153Open DOISearch in Google Scholar
Zhang X, Xun Qu, Cheng-qin Wang, Cheng-jun Zhou, Gui-xiang Liu, Feng-cai Wei, et al. Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line. Acta Pharmacol Sin 2011; 32: 253-8. doi: 10.1038/aps.2010.208ZhangXXunQuCheng-qinWangCheng-junZhouGui-xiangLiuFeng-caiWeiet alOver-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line201132253810.1038/aps.2010.208408571721293478Open DOISearch in Google Scholar
Hollander MC, Sheikh MS, Bulavin D V, Lundgren K, Augeri-henmueller L, Shehee R, et al. Genomic instability in Gadd45a-deficient mice. Nat Genet 1999; 23: 176-84. doi: 10.1038/13802HollanderMCSheikhMSBulavinD VLundgrenKAugeri-henmuellerLSheheeRet alGenomic instability in Gadd45a-deficient mice1999231768410.1038/1380210508513Open DOISearch in Google Scholar
Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response. Mutat Res 2010; 704: 12-20. doi: 10.1016/j.mrrev.2010.01.009CazzaliniOScovassiAISavioMStivalaLAProsperiEMultiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response2010704122010.1016/j.mrrev.2010.01.00920096807Open DOISearch in Google Scholar
Hutchinson MND Mierzwa M, Silva NJ. Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer. Oncogene 2020; 39: 3638-49. doi: 10.1038/s41388-020-1250-3HutchinsonMNDMierzwaMSilvaNJRadiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer20203936384910.1038/s41388-020-1250-3719057032157215Open DOISearch in Google Scholar
Sun C, Wang Z, Song W, Chen B, Zhang J, Dai X, et al. Alteration of DNA damage signaling pathway profile in radiation-treated glioblastoma stem-like cells. Oncol Lett 2015; 10:1769-74. doi: 10.3892/ol.2015.3411SunCWangZSongWChenBZhangJDaiXet alAlteration of DNA damage signaling pathway profile in radiation-treated glioblastoma stem-like cells20151017697410.3892/ol.2015.3411453329126622748Open DOISearch in Google Scholar
Zhao J, Jain A, Iyer RR, Modrich PL, Vasquez KM. Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks. Nucleic Acids Res 2009; 37: 4420-9. doi: 10.1093/nar/gkp399ZhaoJJainAIyerRRModrichPLVasquezKMMismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks2009374420910.1093/nar/gkp399271524919468048Open DOISearch in Google Scholar
Fu X, Hu J, Han HY, Hua YJ, Zhou L, Shuai W Di, et al. High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy. Oncotarget 2015; 6: 28478-90. doi: 10.18632/oncotarget.4424FuXHuJHanHYHuaYJZhouLShuaiW Diet alHigh expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy20156284789010.18632/oncotarget.4424469507326156020Open DOISearch in Google Scholar
Liu Y, Bernauer AM, Yingling CM, Belinsky SA. HIF1a regulated expression of XPA contributes to cisplatin resistance in lung cancer. Carcinogenesis 2012; 33: 1-6. doi: 10.1093/carcin/bgs142LiuYBernauerAMYinglingCMBelinskySAHIF1a regulated expression of XPA contributes to cisplatin resistance in lung cancer2012331610.1093/carcin/bgs142338849122467238Open DOISearch in Google Scholar
Leemans C, Braakhuis B, Brakenhoff R. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22. doi: 10.1038/nrc2982LeemansCBraakhuisBBrakenhoffRThe molecular biology of head and neck cancer20111192210.1038/nrc298221160525Open DOISearch in Google Scholar
Webley K, Bond JA, Jones CJ, Blaydes JP, Craig A, Hupp T, et al. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol Cell Biol 2000; 20: 2803-8. doi: 10.1128/MCB.20.8.2803-2808.2000WebleyKBondJAJonesCJBlaydesJPCraigAHuppTet alPosttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage2000202803810.1128/MCB.20.8.2803-2808.20008549610733583Open DOISearch in Google Scholar
Stiff T, Reis C, Alderton GK, Woodbine L, O’Driscoll M, Jeggo PA. Nbs1 is required for ATR-dependent phosphorylation events. EMBO J 2005; 24: 199-208. doi: 10.1038/sj.emboj.7600504StiffTReisCAldertonGKWoodbineLO’DriscollMJeggoPANbs1 is required for ATR-dependent phosphorylation events20052419920810.1038/sj.emboj.760050454491615616588Open DOISearch in Google Scholar